Open-Label, Pharmacokinetics Study of Caspofungin in Neonates and Infants

Update Il y a 5 ans
Reference: EUCTR2014-005032-34

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate and compare Day 1 C24 hr caspofungin plasma concentrations obtained from neonates and infants <3 months of age administered caspofungin at a 25-mg/m2 intravenous (IV) dose to historical data from adult patients administered caspofungin at a 50-mg daily IV dose.


Inclusion criteria

  • Empirical therapy for fungal infections

Links